158 related articles for article (PubMed ID: 34199018)
1. Cholesterol Levels Affect the Performance of AuNPs-Decorated Thermo-Sensitive Liposomes as Nanocarriers for Controlled Doxorubicin Delivery.
García MC; Naitlho N; Calderón-Montaño JM; Drago E; Rueda M; Longhi M; Rabasco AM; López-Lázaro M; Prieto-Dapena F; González-Rodríguez ML
Pharmaceutics; 2021 Jun; 13(7):. PubMed ID: 34199018
[TBL] [Abstract][Full Text] [Related]
2. pH-temperature dual-sensitive nucleolipid-containing stealth liposomes anchored with PEGylated AuNPs for triggering delivery of doxorubicin.
García MC; Calderón-Montaño JM; Rueda M; Longhi M; Rabasco AM; López-Lázaro M; Prieto-Dapena F; González-Rodríguez ML
Int J Pharm; 2022 May; 619():121691. PubMed ID: 35331830
[TBL] [Abstract][Full Text] [Related]
3. Didodecyldimethylammonium Bromide Role in Anchoring Gold Nanoparticles onto Liposome Surface for Triggering the Drug Release.
Naitlho N; Prieto-Dapena F; Rabasco AM; Rueda M; González-Rodríguez ML
AAPS PharmSciTech; 2019 Aug; 20(7):294. PubMed ID: 31432298
[TBL] [Abstract][Full Text] [Related]
4. Polar Lipid Fraction E from
Ayesa U; Chong PL
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33182284
[TBL] [Abstract][Full Text] [Related]
5. The comparative effect of wrapping solid gold nanoparticles and hollow gold nanoparticles with doxorubicin-loaded thermosensitive liposomes for cancer thermo-chemotherapy.
Li Y; He D; Tu J; Wang R; Zu C; Chen Y; Yang W; Shi D; Webster TJ; Shen Y
Nanoscale; 2018 May; 10(18):8628-8641. PubMed ID: 29697100
[TBL] [Abstract][Full Text] [Related]
6. Liposomal Doxorubicin Delivery Systems: Effects of Formulation and Processing Parameters on Drug Loading and Release Behavior.
Mohammadi ZA; Aghamiri SF; Zarrabi A; Talaie MR
Curr Drug Deliv; 2016; 13(7):1065-1070. PubMed ID: 26708673
[TBL] [Abstract][Full Text] [Related]
7. New liposomal doxorubicin nanoformulation for osteosarcoma: Drug release kinetic study based on thermo and pH sensitivity.
Haghiralsadat F; Amoabediny G; Sheikhha MH; Zandieh-Doulabi B; Naderinezhad S; Helder MN; Forouzanfar T
Chem Biol Drug Des; 2017 Sep; 90(3):368-379. PubMed ID: 28120466
[TBL] [Abstract][Full Text] [Related]
8. Co-delivery of doxorubicin and PSC 833 (Valspodar) by stealth nanoliposomes for efficient overcoming of multidrug resistance.
Bajelan E; Haeri A; Vali AM; Ostad SN; Dadashzadeh S
J Pharm Pharm Sci; 2012; 15(4):568-82. PubMed ID: 23106959
[TBL] [Abstract][Full Text] [Related]
9. Controlled release of a sparingly water-soluble anticancer drug through pH-responsive functionalized gold-nanoparticle-decorated liposomes.
Adhikari C; Das A; Chakraborty A
Chemphyschem; 2015 Mar; 16(4):866-71. PubMed ID: 25586408
[TBL] [Abstract][Full Text] [Related]
10. A comprehensive mathematical model of drug release kinetics from nano-liposomes, derived from optimization studies of cationic PEGylated liposomal doxorubicin formulations for drug-gene delivery.
Haghiralsadat F; Amoabediny G; Helder MN; Naderinezhad S; Sheikhha MH; Forouzanfar T; Zandieh-Doulabi B
Artif Cells Nanomed Biotechnol; 2018 Feb; 46(1):169-177. PubMed ID: 28376641
[TBL] [Abstract][Full Text] [Related]
11. Encapsulation of doxorubicin into thermosensitive liposomes via complexation with the transition metal manganese.
Chiu GN; Abraham SA; Ickenstein LM; Ng R; Karlsson G; Edwards K; Wasan EK; Bally MB
J Control Release; 2005 May; 104(2):271-88. PubMed ID: 15907579
[TBL] [Abstract][Full Text] [Related]
12. Tumor microenvironment sensitive doxorubicin delivery and release to glioma using angiopep-2 decorated gold nanoparticles.
Ruan S; Yuan M; Zhang L; Hu G; Chen J; Cun X; Zhang Q; Yang Y; He Q; Gao H
Biomaterials; 2015 Jan; 37():425-35. PubMed ID: 25453970
[TBL] [Abstract][Full Text] [Related]
13. Aptamer-based liposomes improve specific drug loading and release.
Plourde K; Derbali RM; Desrosiers A; Dubath C; Vallée-Bélisle A; Leblond J
J Control Release; 2017 Apr; 251():82-91. PubMed ID: 28238787
[TBL] [Abstract][Full Text] [Related]
14. Magnetic cationic liposomal nanocarriers for the efficient drug delivery of a curcumin-based vanadium complex with anticancer potential.
Halevas E; Mavroidi B; Swanson CH; Smith GC; Moschona A; Hadjispyrou S; Salifoglou A; Pantazaki AA; Pelecanou M; Litsardakis G
J Inorg Biochem; 2019 Oct; 199():110778. PubMed ID: 31442839
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase-sensitive size-shrinkable nanoparticles for deep tumor penetration and pH triggered doxorubicin release.
Ruan S; Cao X; Cun X; Hu G; Zhou Y; Zhang Y; Lu L; He Q; Gao H
Biomaterials; 2015 Aug; 60():100-10. PubMed ID: 25988725
[TBL] [Abstract][Full Text] [Related]
16. Light induced cytosolic drug delivery from liposomes with gold nanoparticles.
Lajunen T; Viitala L; Kontturi LS; Laaksonen T; Liang H; Vuorimaa-Laukkanen E; Viitala T; Le Guével X; Yliperttula M; Murtomäki L; Urtti A
J Control Release; 2015 Apr; 203():85-98. PubMed ID: 25701610
[TBL] [Abstract][Full Text] [Related]
17. Smart photothermal-triggered bilayer phase transition in AuNPs-liposomes to release drug.
An X; Zhan F; Zhu Y
Langmuir; 2013 Jan; 29(4):1061-8. PubMed ID: 23286691
[TBL] [Abstract][Full Text] [Related]
18. Temperature-triggered tumor-specific delivery of anticancer agents by cRGD-conjugated thermosensitive liposomes.
Kim MS; Lee DW; Park K; Park SJ; Choi EJ; Park ES; Kim HR
Colloids Surf B Biointerfaces; 2014 Apr; 116():17-25. PubMed ID: 24441178
[TBL] [Abstract][Full Text] [Related]
19. Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy.
He Y; Su Z; Xue L; Xu H; Zhang C
J Control Release; 2016 May; 229():80-92. PubMed ID: 26945977
[TBL] [Abstract][Full Text] [Related]
20. Design and evaluation of pH-sensitive liposomes constructed by poly(2-ethyl-2-oxazoline)-cholesterol hemisuccinate for doxorubicin delivery.
Xu H; Hu M; Yu X; Li Y; Fu Y; Zhou X; Zhang D; Li J
Eur J Pharm Biopharm; 2015 Apr; 91():66-74. PubMed ID: 25660909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
